Brief: Pacira Biosciences Sees Double-Digit Compounded Annual Growth Rate In Product Revenue By 2030
10/01/2025 13:12
Jan 10 (Reuters) - Pacira Biosciences Inc PCRX.O :
* PACIRA BIOSCIENCES: SEES DOUBLE-DIGIT COMPOUNDED ANNUAL
GROWTH
RATE IN PRODUCT REVENUE BY 2030
* PACIRA BIOSCIENCES INC: SEES 5 PERCENT POINT GROSS MARGIN
IMPROVEMENT OVER 2024 IN PROFITABILITY BY 2030
* PACIRA BIOSCIENCES: PRELIM Q4 EXPAREL NET PRODUCT SALES OF
$147.7 MILLION
Source text: urn:newsml:reuters.com:*:nGNX99rV9F
Further company coverage: PCRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pacira Biosciences
See all newsBrief: Pacira Biosciences Inc - Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote "For" All Of Pacira's Director Nominees
Brief: Pacira Biosciences Urges Stockholders To Vote "For" Election Of Pacira's Nominees On Blue Proxy Card
Brief: Doma Perpetual Urges Pacira Biosciences Shareholders To Judge Sale Price Adequacy
Brief: Doma Perpetual Capital Management Calls For Removal Of Pacira CEO And Strategic Sale
Brief: Pacira Biosciences Sends Letter To Stockholders Reiterating Superior Qualifications Of Its Board Nominees